Bottom line
What is PMACX's expense ratio?
PMACX's expense ratio is 1.61%, or about $161 a year on every $10,000 invested. That is more expensive than 87% of allocation / balanced funds we track (median 0.91%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Dec 4, 2025
PMACX fee table
| Net expense ratio | 1.61% |
|---|---|
| Gross expense ratio | 1.61% |
| Management fee | 0.46% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 0.14% |
| Acquired fund fees | 0.01% |
| Fee waiver / reimbursement | 0% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Dec 4, 2025
What PMACX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| PMACX | $264 | $508 | $876 | $1,911 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.61% expense ratio costs roughly $84,600 in lost growth, versus about $50,800 for the median allocation / balanced fund (0.91%).